With all of the regulatory changes recently, we cannot know if CL1 will start growing a bit faster again soon or not. I suspect Accounting practices are still not sure exactly what they can and cannot do as far as financial planning is concerned - they will mostly be sticklers to the rules I expect, and will wait to see what others do to raise business.
It is unusual for me to like an acquisition, but this one does actually seem very smart, and the price seems good assuming it does turn out to be eps accretive. It really is a very useful add on. I suspect CL1 will remain in net cash - even if they have a new $10m debt facility in place.
Add to My Watchlist
What is My Watchlist?